Top Core and Group Health Stories
The race is on: Some drugmakers falling behind in developing new weight loss pills
By Emma Court, Robert Langreth and Matthew GriffinDrugmakers have been rushing to develop obesity pills (to rival obesity shots like Wegovy), angling for a piece of a market that some estimate will one day be worth as much as $100 billion.










